New Nordic Healthbrands AB operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares New Nordic Healthbrands AB with three other
pharmaceutical manufacturers in Europe:
sales of 33.59 million Euros [US$39.47 million]
Science In Sport Plc
of UNITED KINGDOM
(£50.57 million [US$65.68 million]
of which 51%
was PhD), and
Venture Life Group plc
based in UNITED KINGDOM
(£20.21 million [US$26.24 million]
of which 67%
was Customer Brands).
New Nordic Healthbrands AB reported sales of SEK 452.61 million (US$51.15 million)
December of 2019.
increase of 15.0%
versus 2018, when the company's sales were SEK 393.71 million.
Sales at New Nordic Healthbrands AB have increased during each of the previous five years
(and since 2014, sales have increased a total of 66%).